The association between plasma IL-6 levels and several thalassemia-related clinical features in Iraqi patients
Keywords:
Interleukin-6, beta-thalassemia, splenectomy, ferritin level, HbF, HbA, blood transfusionAbstract
The present study was set to investigate the potential association between the level of Interleukin-6 (IL-6), as a key component of the pro-inflammatory response, with different thalassemia’s biological and clinical features. For this purpose, one hundred fifty blood samples were collected from 100 beta-thalassemia patients, who attended the Genetic Hematology Centre at Ibn Al- Baladi Hospital in Baghdad, Iraq, and 50 healthy subjects who were employed as a control group. IL-6 levels were estimated using an ELISA Kit, whereas other thalassemia-related clinical features (such as HbA, HbF, ferritin, blood transfusions, splenectomy status, and the history of frequent infection) were additionally assessed. The results of the present study showed a significant elevation (P≤0.01) in the levels of IL-6 in thalassemia patients as compared to healthy controls (57.7763± 8.94837 vs. 6.3059± 1.90364 pg/ml, respectively). Furthermore, IL-6 plasma levels seem to be influenced by the number of multiple scheduled blood transfusions, with the higher IL-6 mean level corresponding to the more frequent transfusions. Also, splenectomized thalassemia patients showed significantly higher IL-6 levels than those of non-splenectomized patients (61.2687±9.30688 vs. 56.9571±8.71926 pg/ml, respectively).
Downloads
References
Viprakasit, V. and S. Ekwattanakit, Clinical classification, screening and diagnosis for thalassemia. Hematology/Oncology Clinics, 2018. 32(2): p. 193-211.
Majeed, M.S., Evaluation of some Biochemical and Endocrine Profiles in transfusion-dependent Iraqi major β-thalassemia patients. Iraqi Journal of Science, 2017. 58(2A): p. 639-45.
Keshk, W.A., et al., Crosstalk between cytokine profile, redox, and iron status in β-Thalassemia: relation to frequency/duration of blood transfusion. Pediatric hematology and oncology, 2019. 36(3): p. 151-160.
Politou, M., et al., The effect of transfusion on immune responses in thalassemia. Blood Cells, Molecules, and Diseases, 2020. 83: p. 102425.
Merchant, R.H., et al., Post splenectomy outcome in β-thalassemia. The Indian Journal of Pediatrics, 2015. 82(12): p. 1097-1100.
Gubernatorova, E.O., et al., Non-redundant functions of IL-6 produced by macrophages and dendritic cells in allergic airway inflammation. Frontiers in immunology, 2018. 9: p. 2718.
Abbas, N.A. and N.A. Zaman, Serological Study of Human Cytomegalovirus in Thalassemia Patients and Blood Donors and its Relation to IL-6 in Kirkuk City. Rafidain Journal of Science, 2019. 28(1): p. 23-28.
Al-Zohairy, L.K. and B.N. AL-Qadhi, Determination of Toxoplasmosis Disease Activity by Estimation of IL-6 Cytokine. Iraqi Journal of Science, 2015. 56(2C): p. 1600-1611.
Noori, N.M., M.N. Moghadam, and A. Teimouri, TNF-α, INTERLEUKIN-6, NT-PRO BNP CORRELATION WITH ECHOCARDIOGRAPHY FINDINGS IN PATIENTS WITH THALASSEMIA. Pakistan Heart Journal, 2019. 52(1).
Moreira, A.C., G. Mesquita, and M.S. Gomes, Ferritin: an inflammatory player keeping iron at the core of pathogen-host interactions. Microorganisms, 2020. 8(4): p. 589.
Nairz, M. and G. Weiss, Iron in infection and immunity. Molecular Aspects of Medicine, 2020. 75: p. 100864.
Sarhat, E.R., M.S. Hamad, and S.J. Khalaf, Leptin, Adiponectin, and Interleukin-6 Levels Among Beta Thalassaemia Patients. Science advance, 2020. 14(127): p. 99-105.
El-Rasheidy, F.H., et al., Elevated serum adiponectin is related to elevated serum ferritin and interleukin-6 in β-thalassaemia major children. Journal of Pediatric Endocrinology and Metabolism, 2016. 29(8): p. 953-958.
Aggeli, C., et al., Endothelial dysfunction and inflammatory process in transfusion-dependent patients with beta-thalassemia major. International journal of cardiology, 2005. 105(1): p. 80-84.
Morabito, N., et al., The “lively” cytokines network in β-thalassemia major-related osteoporosis. Bone, 2007. 40(6): p. 1588-1594.
Surchi, O. and S. Ali, Biochemical Status of Beta-Thalassemia Major Patients in Erbil City. Erbil Dental Journal (EDJ), 2018. 1(1): p. 1-9.
Shah, F.T., et al., Challenges of blood transfusions in β-thalassemia. Blood reviews, 2019. 37: p. 100588.
Sadeghian, M.H., et al., Alloimmunization among transfusion-dependent thalassemia patients. Asian journal of transfusion science, 2009. 3(2): p. 95.
Vento, S., F. Cainelli, and F. Cesario, Infections and thalassaemia. The Lancet infectious diseases, 2006. 6(4): p. 226-233.
Weichselbaum, N., et al., High Interleukin-6 Plasma Concentration upon Admission Is Predictive of Massive Transfusion in Severely Injured Patients. Journal of Clinical Medicine, 2021. 10(11): p. 2268.
Legrand, D., et al., The relationship between grip strength and muscle mass (MM), inflammatory biomarkers and physical performance in community-dwelling very old persons. Archives of gerontology and geriatrics, 2013. 57(3): p. 345-351.
Nakagawa, H., et al., Inverse correlation between serum interleukin-6 and iron levels among Japanese adults: a cross-sectional study. BMC hematology, 2014. 14(1): p. 1-6.
Liu, J., S. Chen, and X. Ye, The effect of red blood cell transfusion on plasma hepcidin and growth differentiation factor 15 in gastric cancer patients: a prospective study. Annals of Translational Medicine, 2019. 7(18).
Miri-Aliabad, G., A. Rezaeifar, and M. Salarzaei, The Comparison of Immunoglobulins Status in Splenectomized and Non-Splenectomized Patients with Major Beta-Thalassemia. Journal of Pediatrics Review: p. 0-0.
Pratummo, K., et al., Hepcidin expression from monocyte of splenectomized and non-splenectomized patients with HbE-β-thalassemia. Hematology, 2014. 19(3): p. 175-180.
Archararit, N., et al., Serum C-reactive protein level in postsplenectomized thalassemic patients. Journal of the Medical Association of Thailand= Chotmaihet Thangphaet, 2000. 83: p. S63-9.
Sari, T.T., et al., Immune response of thalassemia major patients in Indonesia with and without splenectomy. Acta Medica Indonesiana, 2016. 46(3).
Christiansen, T., et al., Exercise training versus diet-induced weight-loss on metabolic risk factors and inflammatory markers in obese subjects: a 12-week randomized intervention study. American Journal of Physiology-Endocrinology and Metabolism, 2010.
Saeed, U., et al., Estimation of hepatitis B virus, hepatitis C virus, and different clinical parameters in the thalassemic population of capital twin cities of Pakistan. Virology: research and treatment, 2015. 6: p. VRT. S31744.
Gupta, S., et al., C-reactive Protein in Periodontitis and its Comparison with Body Mass Index and Smoking Behaviour. Journal of the Nepal Medical Association, 2017. 56(206).
Keikhaei, B., et al., Relationship between serum ferritin and hemoglobin levels determined by cardiac and hepatic T2 MRI in beta-thalassemia intermedia and major patients. Frontiers in biology, 2017. 12(4): p. 311-315.
Cohen, A.R., E. Glimm, and J.B. Porter, Effect of transfusional iron intake on response to chelation therapy in β-thalassemia major. Blood, The Journal of the American Society of Hematology, 2008. 111(2): p. 583-587.
Hershko, C., Pathogenesis and management of iron toxicity in thalassemia. Annals of the New York Academy of Sciences, 2010. 1202(1): p. 1-9.
Haghpanah, S., et al., Relationship between serum hepcidin and ferritin levels in patients with thalassemia major and intermedia in Southern Iran. Iranian Red Crescent Medical Journal, 2015. 17(7).
Ozment, C.P. and J.L. Turi, Iron overload following red blood cell transfusion and its impact on disease severity. Biochimica et Biophysica Acta (BBA)-General Subjects, 2009. 1790(7): p. 694-701.
Melchiori, L., S. Gardenghi, and S. Rivella, β-thalassemia: HiJAKing ineffective erythropoiesis and iron overload. Advances in hematology, 2010. 2010.
Spasiano, A., et al., Setting for “Normal” Serum Ferritin Levels in Patients with Transfusion-Dependent Thalassemia: Our Current Strategy. Journal of Clinical Medicine, 2021. 10(24): p. 5985.
jyA YILMAZ, B.A. and E. Demiralp, Increased plasma levels of interleukin-6 and interleukin-8 in ß-thalassaemia major. Haematologia, 2001. 31(3): p. 237-244.
Belhoul, K.M., et al., Serum ferritin levels and endocrinopathy in medically treated patients with β thalassemia major. Annals of hematology, 2012. 91(7): p. 1107-1114.
Shah, R., et al., Serum ferritin in thalassemia intermedia. Indian Journal of Hematology and Blood Transfusion, 2014. 30(4): p. 281-285.
Schrier, S.L., Pathophysiology of thalassemia. Current opinion in hematology, 2002. 9(2): p. 123-126.
Mabaera, R., et al., A cell stress signaling model of fetal hemoglobin induction: what doesn't kill red blood cells may make them stronger. Experimental hematology, 2008. 36(9): p. 1057-1072.
Sripichai, O. and S. Fucharoen, Fetal hemoglobin regulation in β-thalassemia: heterogeneity, modifiers and therapeutic approaches. Expert review of hematology, 2016. 9(12): p. 1129-1137.
Toksoy, G., et al., Association between HBA locus copy number gains and pathogenic HBB gene variants. International Journal of Medical Biochemistry, 2021. 4(2): p. 91.
Wu, I.-C., et al., Paradoxical relationship between glycated hemoglobin and longitudinal change in physical functioning in older adults: a prospective cohort study. The Journals of Gerontology: Series A, 2019. 74(6): p. 949-956.
Kabyemela, E.R., et al., Fetal Cytokine Balance, Erythropoietin and Thalassemia but Not Placental Malaria Contribute to Fetal Anemia Risk in Tanzania. Frontiers in Immunology, 2021. 12: p. 1121.
Widana, I.K., Sumetri, N.W., Sutapa, I.K., Suryasa, W. (2021). Anthropometric measures for better cardiovascular and musculoskeletal health. Computer Applications in Engineering Education, 29(3), 550–561. https://doi.org/10.1002/cae.22202
Suryasa, I. W., Rodríguez-Gámez, M., & Koldoris, T. (2021). Get vaccinated when it is your turn and follow the local guidelines. International Journal of Health Sciences, 5(3), x-xv. https://doi.org/10.53730/ijhs.v5n3.2938
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
